With the exception of venous thromboembolism and pulmonary embolism events, the antiviral drug did not reduce the incidence of post-COVID-19 conditions in a study of nearly 10,000 US veterans.
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit.A retrospective study of 9593 veterans older than 65 years examined the impact of nirmatrelvir-ritonavir in comparison with no treatment on post-COVID-19 conditions .
Data on COVID-19 treatments and PCCs may be incomplete. The long-term effects of PCCs may not have been fully captured by the International Classification of Diseases, 10th Revision, which was used for diagnosis codes.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Some Cold Medicines Don’t Work. Here’s What Doctors Recommend Instead.With FDA advisers determining that phenylephrine is ineffective, doctors and pharmacists recommend alternatives for congestion relief
Weiterlesen »
Here's how many Utahns have gotten the new COVID-19 shotFewer than 5% of all Utahns have received the latest COVID-19 shot since it was released in mid-September, a rate that lags behind nationwide numbers that are being described as 'abysmal.'
Weiterlesen »
Matthew Perry’s Death Blamed on Covid Vaccine by Twisted Anti-VaxxersFor years, the actor was vocal about his health problems stemming from drug addiction, including 15 rehab stints, 14 surgeries, and a two-week coma.
Weiterlesen »
Nicola Sturgeon's Covid WhatsApp messages were deletedFormer first minister Nicola Sturgeon is reported to have deleted messages relating to the pandemic.
Weiterlesen »
Stem Cell Clinics Are Selling Shady, Unproven Treatments for Long CovidResearchers identified dozens of clinics selling costly, likely worthless stem cell treatments for the chronic, often debilitating condition.
Weiterlesen »
COVID-19 treatments will soon enter the private market with hefty price tagsThe COVID-19 treatments millions of Americans have taken for free from the federal government will enter the private market next week with a hefty price tag.
Weiterlesen »